StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-4.64%)

Close on Nov 18, 2026Market cap $1.53MP/E –Yield –

Vivos Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Vivos Therapeutics's price to book ratio was 5.3× on Jan 30, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 0.9× to 323.8×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20265.3×−1.3
2025Dec 31, 20256.6×+4.0
2024Dec 31, 20242.7×−321.1
2023Dec 29, 2023323.8×+322.8
2022Dec 30, 20220.9×−0.7
2021Dec 31, 20211.6×–

More Vivos Therapeutics figures

See a number that looks wrong?